IP Library Granted Patent US 11,186,850
Granted Patent B2
US 11,186,850 · App. 16/858,163 · Granted Nov 30, 2021

Recombinant yeast cell

Inventors: Ioannis Papapetridis (Delft, NL); Antonius Jeroen Adriaan Van Maris (Stockholm, SE); Jacobus Thomas Pronk (Delft, NL); Paulus Petrus De Waal (Echt, NL); Niels Lauret (Echt, NL); Maarten Dirk Verhoeven (Delft, NL); Jozef Petrus Johannes Schmitz (Echt, NL)
Assignee: DSM IP ASSETS B.V.
C12P7/06C12N1/145C12N1/16C12N9/1205C12N9/88C12N15/81C12R2001/645C12Y207/01019C12Y401/01039Y02E50/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,186,850
App. No.
16/858,163
Granted
Nov 30, 2021
Kind
B2
Abstract

The present invention describes a recombinant yeast cell functionally expressing one or more heterologous nucleic acid sequences encoding for ribulose-1,5-phosphate carboxylase/oxygenase (EC4.1.1.39; Rubisco), and optionally one or more molecular chaperones for Rubisco, and one or more phosphoribulokinase (EC2.7.1.19; PRK), wherein the phosphoribulokinase is under control of a promoter (the “PRK promoter”) that enables higher expression under anaerobic conditions than under aerobic conditions.

Claims (23)

1. A recombinant yeast cell functionally expressing one or more heterologous nucleic acid sequences encoding for ribulose-1,5-phosphate carboxylase/oxygenase (EC4.1.1.39; Rubisco), and one or more phosphoribulokinase (EC2.7.1.19; PRK), wherein the phosphoribulokinase is under control of a promoter or a PRK promoter which has a PRK expression ratio anaerobic/aerobic of 2 or more,

wherein the PRK promoter is the native promoter of a gene selected from the group consisting of: FET4 (FErrous Transport; YMR319C), ANB1 (ANaeroBically induced; YJR047C), YHK8 (YHR048W), DAN1 (Delayed ANaerobic; YJR150C), AAC3 (ADP/ATP Carrier; YBR085W), TIR2 (TIp1-Related; YOR010C), DIP5 (DIcarboxylic amino acid Permease; YPL265W), HEM13 (HEMe biosynthesis; YDR044W), YNR014W, YAR028W, FUN 57, COX5B (Cytochrome c OXidase; YIL111W), OYEZ (Old Yellow Enzyme; YHR179W), SUR2 (SUppressor of Rvs161 and rvs167 mutations; YDR297W), FRDS1 (Fumarate ReDuctase; YEL047C), PIS1 (Phosphatidyl Inositol Synthase; YPR113W), LAC1 (Longevity-Assurance gene Cognate (LAG1 Cognate); YKL008C), YGR035C, FRT2 (Functionally Related to TCP1;YAL028W), EUG1 (ER protein Unnecessary for Growth; YDR518W), HEM14 (HEMe biosynthesis; YER014W), ISU2 (IscU homolog; YOR226C), ERG26 (ERGosterol biosynthesis; YGL001C), MLO01 (Mitochondrially LOcalized protein; YMR252C), SML1 (Suppressor of Mec1 Lethality; YML058W) TIR4 (YOR009W), TIR3 (YIL011W), PAU7 (YAR020C), PAU5 (YFL020C), YLL064C, YGR294W, DAN3 (YBR301W; PAU24), YIL176C, YGL261C, YOL161C, PAU1 (YJL223C), PAU6 (YNR076W), DAN2 (YLR037C; PAU23), YDR542W, YIR041W, YKL224C, PAU3 (YCR104W), YLL025W, YOR394W, YHL046C, YMR325W, YAL068C, YPL282C, PAU2 (YEL049W), and PAU4 (YLR461W).

2. The recombinant yeast cell according to claim 1 , wherein the PRK promoter is ROX1 (“regulation by oxygen 1”)-repressed.

3. The recombinant yeast cell according to claim 1 , wherein the PRK promoter has one or more ROX1 binding motif.

4. The recombinant yeast cell according to claim 1 , wherein PRK promoter comprises in a sequence one or more of motif NNNATTGTTNNN (SEQ ID NO:120).

5. The recombinant yeast cell according to claim 1 , wherein the PRK promoter is the native promoter of a gene selected from the group consisting of: FET4, ANB1, YHR048W, DAN1, AAC3, TIR2, DIP5 and HEM13.

6. The recombinant yeast cell according to claim 1 , wherein the PRK promoter comprises in a sequence thereof one or more of: TCGTTYAG (SEQ ID NO:121); AAAAATTGTTGA (SEQ ID NO:122); or TCGTTYAG (SEQ ID NO:121) and AAAAATTGTTGA (SEQ ID NO:122).

7. The recombinant yeast cell according to claim 1 , wherein the PRK promoter is the native promoter of a gene selected from the group consisting of: TIR2, DAN1, TIR4, TIR3, PAU7, PAU5, YLL064C, YGR294W, DAN3, YIL176C, YGL261C, YOL161C, PAU1, PAU6, DAN2, YDR542W, YIR041W, YKL224C, PAU3, YLL025W.

8. The recombinant yeast strain according to claim 1 , wherein the PRK promoter is a synthetic oligonucleotide.

9. The recombinant yeast cell according to claim 1 , wherein the PRK promoter enables expression only during anaerobic conditions.

10. The recombinant yeast cell according to claim 1 , wherein the PRK promoter is the promoter of ANB1; DAN1; or ANB1 and DAN1.

11. The recombinant yeast cell according to claim 1 wherein the Rubisco is under a constitutive promotor.

12. The recombinant yeast cell according to claim 1 in which:

one or more genes of a non-oxidative branch of pentose phosphate pathway are overexpressed;

the yeast cell comprises a deletion or disruption of a glycerol-3-phosphate dehydrogenase (GPD) gene; or

one or more genes of a non-oxidative branch of pentose phosphate pathway are overexpressed and the yeast cell comprises a deletion or disruption of a glycerol-3-phosphate dehydrogenase (GPD) gene.

13. A process for preparing an organic compound, the process comprising converting a carbon source using the recombinant yeast cell according to claim 1 , thereby forming the organic compound.

14. The recombinant yeast cell according to claim 1 , said cell further functionally expressing one or more heterologous nucleic acid sequences encoding one or more molecular chaperones for Rubisco.

15. The process of claim 13 , wherein the organic compound is an alcohol and the carbon source is a carbohydrate.

16. The recombinant yeast cell according to claim 1 , wherein the PRK promoter is the native promoter of a gene selected from the group consisting of:

FET4, ANB1, YHK8, DAN1, AAC3, TIR2, DIP5, HEM13, YNR014W, YAR028W, FUN 57, COX5B, OYEZ, SUR2, FRDS1, PIS1, LAC1, YGR035C, FRT2, EUG1, HEM14, ISU2, ERG26, MLO1, and SML1.

17. The recombinant yeast cell according to claim 1 , wherein the PRK promoter is the native promoter of a gene selected from the group consisting of:

TIR2, DAN1, TIR4, TIR3, PAU7, PAU5, YLL064C, YGR294W, DAN3, YIL176C, YGL261C, YOL161C, PAU1, PAU6, DAN2, YDR542W, YIR041W, YKL224C, PAU3, YLL025W, YOR394W, YHL046C, YMR325W, YAL068C, YPL282C, PAU2, and PAU4.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2023
From: DSM IP ASSETS B.V.
To: DANISCO US INC.
Reel/Frame 066005/0848 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2020
From: PAPAPETRIDIS, IOANNIS; VAN MARIS, ANTONIUS JEROEN ADRIAAN; PRONK, JACOBUS THOMAS; DE WAAL, PAULUS PETRUS; LAURET, NIELS; VERHOEVEN, MAARTEN; SCHMITZ, JOZEF PETRUS JOHANNES
To: DSM IP ASSETS B.V.
Reel/Frame 052492/0650 →
Priority Claims (1)
EP 16174382 · Jun 14, 2016 · regional
Continuity (2)
Continuation 16309422
Related Publication 20200255871A1 · Aug 13, 2020
Cited By (1)
US 12,398,398